2022 | | A phase IA dose-escalation study of PHI-101, a new checkpoint kinase 2 inhibitor, for platinum-resistant recurrent ovarian cancer | 공태욱, 장석준 |
2019 | | Association Between Radiation Tolerance of Lymphocytes and Clinical Outcomes in Cervical Cancer | 공태욱, 이용희, 이은주, 장석준, 전미선, 조오연 |
2019 | | Comparison of posterior rectal dissection techniques during rectosigmoid colon resection as part of cytoreductive surgery in patients with epithelial ovarian cancer: Close rectal dissection versus total mesorectal excision | 공태욱, 백지흠, 손주혁, 유희석, 장석준 |
2024 | | Effect of high-dose polymeric nanoparticle micellar paclitaxel on improved progression-free survival in patients with optimally resected stage III or IV high-grade carcinoma of the ovary: a prospective cohort study with historical controls | 공태욱, 손주혁, 장석준 |
2023 | | Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1–2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001) | 공태욱, 김지연, 손주혁, 장석준 |
2022 | | Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators Collaboration (GORILLA) group (GORILLA-1001) | 공태욱, 손주혁, 장석준 |
2022 | | Gynecologic cancer clinical practice guidelines in Korea and current issues | 공태욱, 김지연, 손주혁, 장석준 |
2020 | | High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology | 공태욱 |
2020 | | High-risk human papillomavirus testing as a primary screening for cervical cancer: Position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology | 공태욱 |
2023 | | Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003) | 공태욱, 김지연, 손주혁, 장석준 |
2023 | | Major clinical research advances in gynecologic cancer in 2022: highlight on late-line PARP inhibitor withdrawal in ovarian cancer, the impact of ARIEL-4, and SOLO-3 | 공태욱 |
2024 | | Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer | 공태욱, 손주혁 |
2019 | | Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement | 공태욱 |
2023 | | Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion group (GORILLA-3001) | 공태욱, 손주혁, 장석준 |
2020 | | Prognostic analysis of splenic parenchymal metastasis in advanced ovarian cancer: Does parenchymal metastasis matter? | 공태욱, 백지흠, 손주혁, 장석준 |
2020 | | Prognostic factors influencing pelvic, extra-pelvic, and intraperitoneal recurrences in lymph node-negative early-stage cervical cancer patients following radical hysterectomy | 공태욱, 백지흠, 손주혁, 장석준 |
2023 | | Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004) | 공태욱, 김지연, 손주혁, 장석준 |
2022 | | Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol | 공태욱, 장석준 |
2020 | | Selection criteria and colpotomic approach for safe minimally invasive radical hysterectomy in early-stage cervical cancer | 공태욱, 백지흠, 손주혁, 유희석, 장석준 |
2023 | | Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer | 공태욱, 김지연, 손주혁, 장석준 |
2022 | | Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer | 공태욱, 김지연, 손주혁, 장석준 |
2020 | | Spillage and displacement of ICG-stained tissue from the uterine cervix to the pelvic peritoneum: A proof of concept study for colpotomic approach in minimally invasive surgery | 공태욱, 백지흠, 손주혁, 장석준 |
2020 | | Survival outcomes of FIGO stage IIIC and IVB endometrial cancer patients presenting primarily as nodal spreads without peritoneal carcinomatosis | 공태욱, 백지흠, 손주혁, 장석준 |
2021 | | Treatment outcomes and complications in FIGO stage IIIC and IVB endometrioid endometrial cancer patients presenting as nodal spreads following systematic lymphadenectomy and adjuvant therapy | 공태욱, 백지흠, 손주혁, 장석준 |